Covid-19 roundup: Ox­ford in­ves­ti­ga­tor sees 's­mall chance' for vac­cine roll­out by year end; Fo­s­un fol­lows Pfiz­er with fi­nal choice of BioN­Tech can­di­date

Ox­ford Uni­ver­si­ty is “op­ti­mistic” it will have late-stage tri­al re­sults for its Covid-19 vac­cine with As­traZeneca this year, which could set it up for a speedy ap­proval at the end of De­cem­ber or in ear­ly 2021.

At the UK’s Sci­ence and Tech­nol­o­gy Com­mit­tee and Health and So­cial Care Com­mit­tee meet­ing on Wednes­day, vac­cine tri­al chief in­ves­ti­ga­tor An­drew Pol­lard said Ox­ford is get­ting clos­er to a read­out. “I’m op­ti­mistic that we could reach that point be­fore the end of this year,” he said, re­mark­ing that there’s a “small chance” Britain could roll out the vac­cine be­fore Christ­mas. “But I just don’t know,” he said.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.